503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1.44%
Net income growth under 50% of BB's 127.14%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
32.41%
D&A growth well above BB's 1.14%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-127.78%
Both reduce yoy usage, with BB at -168.43%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-127.78%
Both reduce yoy usage, with BB at -100.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
No Data
No Data available this quarter, please select a different quarter.
-33.87%
Both yoy CFO lines are negative, with BB at -143.37%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-57.27%
Negative yoy CapEx while BB is 100.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-103.13%
Negative yoy purchasing while BB stands at 100.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-1601.12%
Both yoy lines negative, with BB at -129.80%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-371.47%
We reduce yoy invests while BB stands at 1.76%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-20.08%
Both yoy lines negative, with BB at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
93.28%
Buyback growth of 93.28% while BB is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.